Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SITAR: R940343 in allergic asthma
NCT01591044Phase 2Completed
- Sponsor
- Rigel Pharmaceuticals, Inc.
- Start
- Jul 2012
- Primary completion
- Jul 2013
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of R343 in allergic asthma, sponsored by Rigel Pharmaceuticals, Inc.. Started Jul 2012; status: completed.
02
Drugs
R343
03
Conditions
allergic asthma
Beyond the preview
Go deeper on NCT01591044.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01591044.